Videos |
|
xi | |
Foreword |
|
xii | |
Preface |
|
xiii | |
Contributors |
|
xiv | |
|
1 Detection of Microbes in Orthopaedic Infections |
|
|
1 | (17) |
|
|
|
|
|
1 | (1) |
|
1.2 Culture-Based Microbiology |
|
|
2 | (8) |
|
1.2.1 Limitations of Culture-Based Microbiology |
|
|
3 | (1) |
|
1.2.2 Detection of Microbes in Biofilm |
|
|
4 | (1) |
|
1.2.3 Infections with Atypical Organisms |
|
|
4 | (1) |
|
1.2.4 Orthopaedic Hardware Infections |
|
|
5 | (3) |
|
1.2.5 Native Bone and Joint Infections |
|
|
8 | (2) |
|
|
10 | (3) |
|
1.3.1 Polymerase Chain Reaction (PCR) |
|
|
10 | (2) |
|
1.3.2 Next-Generation Sequencing (NGS) |
|
|
12 | (1) |
|
|
13 | (5) |
|
2 Antibiotics for Orthopaedic Infections |
|
|
18 | (16) |
|
|
|
|
18 | (7) |
|
|
18 | (1) |
|
2.1.2 Antibiotic Selection and Administration |
|
|
19 | (2) |
|
2.1.3 Intravenous versus Oral Antibiotics |
|
|
21 | (4) |
|
|
25 | (1) |
|
|
25 | (1) |
|
2.2.2 Chlorhexidine (Gluconate/Digluconate) |
|
|
26 | (1) |
|
2.3 Carriers that may be Associated with Antibiotics |
|
|
26 | (1) |
|
|
26 | (2) |
|
|
27 | (1) |
|
2.4 Antibiotics for Use in Carriers |
|
|
28 | (2) |
|
2.4.1 Gentamicin/Tobramycin |
|
|
30 | (1) |
|
|
30 | (1) |
|
|
30 | (1) |
|
|
30 | (1) |
|
2.7 Collaboration between Orthopaedic Surgeons and Infectious Disease Specialists |
|
|
31 | (1) |
|
|
31 | (3) |
|
3 Irrigation Solutions for Orthopaedic Infections |
|
|
34 | (12) |
|
|
|
|
|
|
34 | (2) |
|
3.1.1 Overview of Antiseptic Agents |
|
|
34 | (1) |
|
3.1.2 Efficacy as Surgical Wound Irrigant |
|
|
35 | (1) |
|
3.2 Bacitracin and Polymyxin |
|
|
36 | (1) |
|
3.2.1 Overview of Antiseptic Agent |
|
|
36 | (1) |
|
3.2.2 Efficacy as a Surgical Wound Irrigant |
|
|
36 | (1) |
|
3.3 Dilute Povidone-lodine (PI) |
|
|
37 | (2) |
|
3.3.1 Overview of Antiseptic Agent |
|
|
37 | (1) |
|
3.3.2 Efficacy as a Surgical Wound Irrigant |
|
|
38 | (1) |
|
|
39 | (1) |
|
3.4.1 Overview of Antiseptic Agent |
|
|
39 | (1) |
|
3.4.2 Efficacy as a Surgical Wound Irrigant |
|
|
40 | (1) |
|
3.5 Sodium Hypochlorite (NaOCI) |
|
|
40 | (1) |
|
3.5.1 Overview of Antiseptic Agent |
|
|
40 | (1) |
|
3.5.2 Efficacy as a Surgical Wound Irrigant |
|
|
41 | (1) |
|
|
41 | (1) |
|
3.6.1 Overview of Antiseptic Agent |
|
|
41 | (1) |
|
3.6.2 Efficacy as a Surgical Wound Irrigant |
|
|
42 | (1) |
|
|
42 | (4) |
|
4 Surgical Wound Dressings after Treating Orthopaedic Infections |
|
|
46 | (15) |
|
|
|
|
46 | (1) |
|
4.2 Characteristics of Optimal Surgical Dressings |
|
|
47 | (1) |
|
|
48 | (9) |
|
4.3.1 Nonocclusive and Occlusive Dressings |
|
|
48 | (4) |
|
4.3.2 Dressing Application Tips and Tricks |
|
|
52 | (1) |
|
4.3.3 Wound Vacuum Systems |
|
|
53 | (4) |
|
4.4 Algorithm for Surgical Dressing Selection |
|
|
57 | (1) |
|
|
58 | (3) |
|
|
61 | (27) |
|
|
|
61 | (1) |
|
|
62 | (2) |
|
|
64 | (5) |
|
|
64 | (2) |
|
5.3.2 Type 2 (Superficial) |
|
|
66 | (2) |
|
|
68 | (1) |
|
|
68 | (1) |
|
|
69 | (4) |
|
|
69 | (1) |
|
|
69 | (1) |
|
|
69 | (3) |
|
5.4.4 Microbiological Diagnosis |
|
|
72 | (1) |
|
5.4.5 Histological Diagnosis |
|
|
72 | (1) |
|
|
73 | (1) |
|
|
73 | (2) |
|
5.7 Treatment of Osteomyelitis |
|
|
75 | (10) |
|
5.7.1 General Considerations |
|
|
75 | (2) |
|
5.7.2 Acute Osteomyelitis |
|
|
77 | (1) |
|
5.7.3 Chronic Osteomyelitis |
|
|
77 | (1) |
|
5.7.4 Operative Treatment |
|
|
78 | (1) |
|
|
79 | (1) |
|
|
79 | (2) |
|
5.7.7 Antimicrobial Therapy |
|
|
81 | (1) |
|
5.7.8 Dead Space Management |
|
|
82 | (1) |
|
|
82 | (3) |
|
5.7.10 Soft-Tissue Coverage |
|
|
85 | (1) |
|
5.7.11 Staging of Surgery |
|
|
85 | (1) |
|
|
85 | (3) |
|
6 Treatment of the Septic Native Joint |
|
|
88 | (13) |
|
|
|
|
88 | (1) |
|
|
89 | (4) |
|
|
89 | (1) |
|
|
90 | (1) |
|
6.2.3 Clinical Manifestations |
|
|
90 | (1) |
|
|
91 | (1) |
|
|
91 | (2) |
|
|
93 | (1) |
|
|
93 | (5) |
|
|
93 | (1) |
|
6.3.2 Gonococcal Arthritis |
|
|
94 | (1) |
|
|
94 | (1) |
|
6.3.4 Antimicrobial Therapy |
|
|
94 | (1) |
|
|
95 | (1) |
|
|
95 | (1) |
|
6.3.7 Arthroscopic Treatment |
|
|
95 | (1) |
|
|
96 | (2) |
|
|
98 | (3) |
|
7 Management of Periprosthetic Joint Infection |
|
|
101 | (21) |
|
|
|
|
101 | (2) |
|
7.2 Chronicity of Infection |
|
|
103 | (1) |
|
7.3 Antibiotic Management Alone |
|
|
104 | (1) |
|
7.4 Irrigation and Debridement |
|
|
104 | (1) |
|
7.4.1 Irrigation and Debridement without Polyethylene Exchange |
|
|
104 | (1) |
|
|
105 | (2) |
|
7.6 One-Stage Exchange Arthroplasty |
|
|
107 | (4) |
|
|
108 | (1) |
|
|
108 | (1) |
|
|
109 | (1) |
|
7.6.4 New Prosthesis Implantation |
|
|
109 | (1) |
|
7.6.5 Outcomes of One-Stage Exchange Arthroplasty |
|
|
110 | (1) |
|
7.7 Two-Stage Exchange Arthroplasty |
|
|
111 | (3) |
|
7.7.1 First Stage: Debridement and Antibiotic Spacer Implantation |
|
|
111 | (2) |
|
7.7.2 Second Stage: Reimplantation |
|
|
113 | (1) |
|
7.7.3 Outcomes of Two-Stage Exchange Arthroplasty |
|
|
114 | (1) |
|
7.8 Salvage Procedures for PJI |
|
|
114 | (1) |
|
|
115 | (7) |
|
8 Infection after Fracture Fixation and Infected Nonunions |
|
|
122 | (13) |
|
|
|
8.1 Antibiotic Prophylaxis for Open Fractures |
|
|
122 | (2) |
|
|
124 | (1) |
|
|
124 | (1) |
|
|
124 | (1) |
|
|
124 | (4) |
|
|
124 | (3) |
|
8.3.2 Computed Tomography |
|
|
127 | (1) |
|
8.3.3 Magnetic Resonance Imaging |
|
|
127 | (1) |
|
8.3.4 Nuclear Medicine Studies |
|
|
128 | (1) |
|
|
128 | (1) |
|
|
128 | (1) |
|
|
129 | (1) |
|
|
129 | (3) |
|
8.5.1 Irrigation Solutions |
|
|
129 | (1) |
|
8.5.2 Pin Tract Infections |
|
|
130 | (1) |
|
8.5.3 Irrigation and Debridement with Hardware Retention |
|
|
130 | (1) |
|
8.5.4 Irrigation and Debridement with Hardware Removal |
|
|
131 | (1) |
|
8.5.5 Irrigation and Debridement and Revision Fracture Surgery-One-Stage |
|
|
131 | (1) |
|
8.5.6 Irrigation and Debridement with Hardware Removal and Antibiotic Spacer Placement--Two-Stage |
|
|
131 | (1) |
|
|
132 | (1) |
|
|
132 | (1) |
|
|
132 | (3) |
|
|
135 | (16) |
|
|
|
9.1 Spinal Epidural Abscesses |
|
|
135 | (5) |
|
9.1.1 Introduction and Epidemiology |
|
|
135 | (1) |
|
9.1.2 Anatomy and Pathogenesis |
|
|
136 | (1) |
|
9.1.3 Presentation and Diagnosis |
|
|
136 | (2) |
|
9.1.4 Management and Surgical Decision-Making |
|
|
138 | (2) |
|
|
140 | (1) |
|
9.2 Vertebral Osteomyelitis and Diskitis |
|
|
140 | (6) |
|
9.2.1 Introduction and Epidemiology-- |
|
|
140 | (1) |
|
9.2.2 Anatomy and Pathogenesis |
|
|
141 | (1) |
|
9.2.3 Presentation and Diagnosis |
|
|
142 | (1) |
|
9.2.4 Management and Surgical Decision-Making |
|
|
143 | (2) |
|
|
145 | (1) |
|
|
146 | (5) |
|
|
151 | (20) |
|
|
|
|
|
|
151 | (1) |
|
10.2 Risk Factors for Craft Infection |
|
|
152 | (3) |
|
10.2.1 The Effect of Graft Type on Rates of Postoperative Infection |
|
|
152 | (3) |
|
10.3 Clinical Presentation and Management |
|
|
155 | (2) |
|
10.3.1 Clinical Presentation |
|
|
155 | (1) |
|
10.3.2 Laboratory Evaluation |
|
|
156 | (1) |
|
10.3.3 Surgical Site Infection versus Intra-articular Graft Infection |
|
|
157 | (1) |
|
10.3.4 Organisms Responsible for Graft Infection |
|
|
157 | (1) |
|
10.4 Management of Craft Infection |
|
|
157 | (8) |
|
10.4.1 Nonsurgical Management |
|
|
157 | (1) |
|
10.4.2 Surgical Management of Graft Infection |
|
|
158 | (4) |
|
|
162 | (1) |
|
10.4.4 Hardware Retention |
|
|
163 | (1) |
|
10.4.5 Graft Replantation |
|
|
163 | (1) |
|
10.4.6 Antibiotic Management |
|
|
164 | (1) |
|
10.5 Outcomes and Complications |
|
|
165 | (1) |
|
10.5.1 Recurrent Instability and Reoperation |
|
|
165 | (1) |
|
10.5.2 Patient Reported Outcomes Following Graft Infection |
|
|
165 | (1) |
|
10.5.3 Graft Infection Cost |
|
|
165 | (1) |
|
10.6 Craft Infection Prevention |
|
|
166 | (1) |
|
10.6.1 Intraoperative Graft Antibiotics |
|
|
166 | (1) |
|
10.7 Intraoperative Autograft Contamination |
|
|
166 | (1) |
|
|
167 | (4) |
Index |
|
171 | |